AI-Driven Predictive Modeling for Accelerated Drug Discovery and Personalized Medicine Development

The research investigates how AI-driven predictive modelling can revolutionize personalized medicine and speed up drug discovery. Through the utilization of sophisticated machine learning algorithms and vast biomedical datasets, the research endeavours to expedite the identification of auspicious medication candidates and customize therapies to specific patient profiles. According to the research, AI models considerably improve predictions of drug-target interactions, anticipate side effects, and pinpoint important biomarkers for patient classification. These AI-driven techniques perform better than conventional methods in terms of processing speed and predicted accuracy, which speeds up the process of finding efficient medications and individualized treatment regimens. This research holds the potential to completely transform the pharmaceutical sector by cutting down on the duration and expenses associated with medication development and enhancing patient outcomes via more focused treatments. AI technologies enable a significant improvement in the accuracy and effectiveness of medical treatments; the model shows a 20% increase in accuracy over conventional approaches.